Breadcrumb

August 2022 MolMed Mini Symposium

Astellas Pharma Inc.

 

 

 

The mini-symposium is for Faculty, postdocs, graduate students, and project scientists, who have an interest in translational research. Poster presentations are encouraged on the general topics of drug discovery, translational research, and particularly in target identification and validation studies in oncology, immuno-sciences, and other disease areas. Poster presentations could spark possible collaboration opportunities with our guests, Astellas Pharmaceuticals. 

Join us for a mini reception immediately following the symposium.

Advance registration is required.
 
August 2022 MOLMED Mini Symposium Registration:
https://ucriverside.az1.qualtrics.com/jfe/form/SV_1Og3cl95A4lEJL0

August 2022 MolMed Mini Symposium Agenda

Moderated by Maurizio Pellecchia, Ph.D., Director-MolMed Center

1:30pm
Welcome and Introduction
Rodolfo Torres, VC RED
1:35pm
Immune biomarkers and targets for sepsis through single cell sequencing and timed analysis
Meera Nair, Ph.D., UCR SOM 
1:55pm
Target Human Ubl Pathways as a Novel Strategy for Anti-viruses and Anticancers with KRAS Mutations
Jiayu Liao, Ph.D., UCR BCOE
2:15pm
Immuno-oncology Target Suited for Small Molecule Approaches
Michael Pirrung, Ph.D., UCR CNAS
2:35pm
Engineering Biomaterials for Tissue Repair and Drug Delivery
Huinan Liu, Ph.D., UCR BCOE
2:55pm Break
3:15pm
The University of California Drug Discovery Consortium (UCDDC)
Maurizio Pellecchia, Ph.D., UCR SOM
3:30pm
Keynote Presentation - Astellas: Driving Innovation through Partnerships
Astellas Pharma, Inc.
4:00pm
MRB Incubator Tour & Poster Session
David Pearson, Ph.D., UCR Technology Partnerships
5:00pm
Adjourn